This is a non-core endpoint: only basic statistics are computed.
Myelodysplastic syndrome
C3_MYELODYSP_SYNDR
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
712 |
4. Check minimum number of eventsNone |
712 |
5. Include endpointsNone |
712 |
6. Filter based on genotype QC (FinnGen only) |
479 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Myelodysplastic syndrome
based on the number of shared cases.
Similar with more cases:
- Acute myeloid leukaemia and myelodysplastic syndromes
- Myelodysplastic syndrome, including Hilmo
- Liquid cancers
- Liquid cancers, including Hilmo
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 479 | 176 | 303 |
| Unadjusted period prevalence (%) | 0.11 | 0.06 | 0.14 |
| Median age at first event (years) | 76.48 | 75.95 | 76.79 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 505
- Matched controls
- 5050
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WW500
NOMESCO Finland
Blood transfusion
70.2
307.7
190
43
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
3111.1
307.7
280
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1921.2
307.7
308
*
XW000
NOMESCO Finland
Bone marrow biopsy
110.5
307.7
286
59
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
+∞
307.7
299
*
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
2231.7
270.5
238
*
B03XA02
ATC
darbepoetin alfa; parenteral
61.5
243.0
139
31
D64.9
ICD-10 Finland
Anaemia, unspecified
14.8
215.8
298
449
A04AA01
ATC
ondansetron; systemic, rectal
40.2
210.0
134
45
B03XA01
ATC
erythropoietin; parenteral
79.9
139.5
75
11
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
29.0
136.4
95
40
Z51.5
ICD-10 Finland
Palliative care
11.8
114.5
134
150
L03AA02
ATC
filgrastim; parenteral
+∞
109.4
101
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
+∞
100.4
93
*
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
768.1
69.8
67
*
JN4AD
NOMESCO Finland
Body CT examination
8.0
68.7
105
160
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
68.3
64
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
104.8
66.9
72
8
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
63.9
60
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.4
62.2
155
380
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
+∞
60.7
57
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
59.6
56
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
104.5
59.4
64
7
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
328.4
58.6
58
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
625.7
57.9
56
*
R50.9
ICD-10 Finland
Fever, unspecified
4.8
52.9
150
405
306
Kela drug reimbursment
Erythropoietin and darbepoetin
+∞
49.8
47
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
13.3
45.9
45
37
B82
ICPC
Anaemia other/unspecified
8.3
44.2
62
84
H02AB02
ATC
dexamethasone; systemic
18.7
43.2
35
20
9982/3-C42.1
ICD-O-3
Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia of bone marrow
+∞
42.3
40
*
116
Kela drug reimbursment
Prostate cancer
+∞
41.2
39
*
ZX112
NOMESCO Finland
Subcutaneous
63.0
40.0
46
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.6
40.0
114
304
JN4BD
NOMESCO Finland
Extensive body CT
6.6
38.0
66
113
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
395.0
37.5
37
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
102.5
35.2
38
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
34.8
33
*
N02AA05
ATC
oxycodone; systemic
3.5
33.8
155
571
D64.8
ICD-10 Finland
Other specified anaemias
10.5
33.4
38
39
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
32.7
31
*
L04AD01
ATC
ciclosporin; systemic
38.3
31.0
39
11
L01XX05
ATC
hydroxycarbamide; oral
170.4
31.0
32
*
ZX120
NOMESCO Finland
Intravenous
5.1
30.9
71
157
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
30.8
321
1859
127
Kela drug reimbursment
Transplant complication
40.9
30.7
38
10
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
320.6
30.1
30
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
29.5
28
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
28.4
27
*
V03AC03
ATC
deferasirox; oral
+∞
27.3
26
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.7
27.3
101
320
J01MA12
ATC
levofloxacin; systemic
3.1
27.3
152
620
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
285.5
27.0
27
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.7
25.1
62
145
H02AB06
ATC
prednisolone; systemic
2.6
25.0
294
1743
J02AC03
ATC
voriconazole; systemic
136.8
24.8
26
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
24.7
242
1312
SPAT1088
SPAT
Blood transfusion
51.1
24.5
29
6
M04AA01
ATC
allopurinol; systemic
2.9
24.3
143
597
9980/3-C42.1
ICD-O-3
Myelodysplastic syndrome with single lineage dysplasia of bone marrow
+∞
24.2
23
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.3
23.7
32
41
WF002
NOMESCO Finland
Radical radiotherapy
87.6
22.9
25
*
A05AA02
ATC
ursodeoxycholic acid; oral
19.5
22.0
33
18
L03AA13
ATC
pegfilgrastim; parenteral
120.3
21.8
23
*
JN6AD
NOMESCO Finland
CT of torso and neck
27.9
21.6
29
11
WW200
NOMESCO Finland
Immunization
7.4
21.0
31
44
9985/3-C42.1
ICD-O-3
Myelodysplastic syndrome with multilineage dysplasia of bone marrow
+∞
21.0
20
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
218.6
20.7
21
*
D46.4
ICD-10 Finland
Refractory anaemia, unspecified
218.6
20.7
21
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.1
20.7
62
168
WZC00
NOMESCO Finland
Treatment plan or consultation
2.6
20.6
155
728
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.6
20.0
39
74
TGC00
NOMESCO Finland
Bronchial lavation
5.9
18.9
35
63
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
18.6
213
1201
130
Kela drug reimbursment
Malignant tumour
+∞
17.8
17
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
17.8
17
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
17.8
17
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
17.8
17
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.2
17.8
50
129
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
17.5
255
1579
J05AB11
ATC
valaciclovir; oral
2.9
17.1
95
378
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.5
16.8
42
99
115
Kela drug reimbursment
Breast cancer
+∞
16.8
16
*
175
Kela drug reimbursment
Deferasirox
+∞
16.8
16
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.6
16.7
24
33
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
16.4
80
296
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
49.2
16.1
19
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.7
16.1
55
163
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
+∞
15.7
15
*
399
Kela drug reimbursment
Venetoclax
+∞
15.7
15
*
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
+∞
15.7
15
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
87.9
15.7
17
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
15.3
181
1019
B02AA02
ATC
tranexamic acid; systemic
3.2
14.9
63
214
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
14.7
14
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
14.7
14
*
L01XX52
ATC
venetoclax; oral
+∞
14.7
14
*
1518, ,
Kela drug reimbursment
+∞
14.7
14
*
D46
ICD-10 Finland
Myelodysplastic syndromes
+∞
14.7
14
*
L02BB03
ATC
bicalutamide; oral
+∞
14.7
14
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
14.7
14
*
GD1AD
NOMESCO Finland
Thorax CT examination
3.7
14.1
47
137
R04.0
ICD-10 Finland
Epistaxis
2.9
13.9
70
263
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
24.6
13.9
19
8
A02BC02
ATC
pantoprazole; systemic
2.1
13.6
351
2607
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
13.6
13
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
13.6
13
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.8
13.5
31
68
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
12.6
13.2
23
19
A41.9
ICD-10 Finland
Sepsis, unspecified
3.7
12.7
41
117
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
71.7
12.6
14
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
+∞
12.5
12
*
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
+∞
12.5
12
*
1BC07, ,
NOMESCO Finland
+∞
12.5
12
*
L02BG04
ATC
letrozole; oral
133.2
12.5
13
*
Y77
ICPC
Malignant neoplasm prostate
133.2
12.5
13
*
C03CA01
ATC
furosemide; systemic
2.0
12.4
262
1788
XX3DW
NOMESCO Finland
Time consuming IT work
3.9
12.3
37
100
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
47.9
11.9
14
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
30.8
11.7
15
5
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
11.5
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
11.5
11
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
11.5
11
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
11.5
11
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
122.7
11.5
12
*
UJF32
NOMESCO Finland
Coloscopy
2.1
11.2
141
797
J01MA14
ATC
moxifloxacin; systemic
2.7
11.2
63
251
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
11.1
88
413
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.4
11.1
41
128
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
44.3
11.0
13
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
44.3
11.0
13
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.6
10.9
37
109
L04AA06
ATC
mycophenolic acid; systemic
10.9
10.9
20
19
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
10.8
125
684
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
10.7
123
671
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
61.3
10.7
12
*
B99
ICPC
Blood/lymph/spleen disease other
61.3
10.7
12
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.8
10.6
22
26
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
10.6
53
198
122
Kela drug reimbursment
Aplastic anaemia
112.3
10.5
11
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
10.4
10
*
WW500, ,
SPAT
+∞
10.4
10
*
B73
ICPC
Leukaemia
+∞
10.4
10
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.9
10.3
31
84
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
10.2
126
705
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
10.1
74
334
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
15.0
10.1
16
11
NK6AN
NOMESCO Finland
Total body bone isotope imaging
40.9
10.0
12
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
9.9
52
199
J02AC01
ATC
fluconazole; systemic
1.9
9.9
149
893
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.6
9.8
33
97
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.9
9.6
21
44
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
18.0
9.4
14
8
B74
ICPC
Malignant neoplasm blood other
101.9
9.4
10
*
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
9.4
9
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
9.4
9
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.4
9
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.2
9.3
25
62
L57.0
ICD-10 Finland
Actinic keratosis
2.5
9.3
63
274
J01DB01
ATC
cefalexin; oral
1.9
9.2
381
3099
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
15.9
9.1
14
9
B02BX05
ATC
eltrombopag; oral
37.4
9.0
11
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
37.4
9.0
11
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
24.5
8.9
12
5
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
14.4
8.7
14
10
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
50.9
8.7
10
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
20.4
8.5
12
6
WF049
NOMESCO Finland
Radiotherapy of metastasis
91.5
8.4
9
*
TPH00
NOMESCO Finland
Phlebotomy
91.5
8.4
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
91.5
8.4
9
*
D45
ICD-10 Finland
Polycythaemia vera
91.5
8.4
9
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.0
8.4
38
134
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
8.4
8
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
8.4
8
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
8.4
8
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
8.4
8
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
8.4
8
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
8.4
8
*
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
+∞
8.4
8
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.3
8.3
21
50
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
8.2
151
958
HA1AA
NOMESCO Finland
X-ray mammography
4.1
8.1
22
55
J01MA02
ATC
ciprofloxacin; systemic
1.7
8.1
214
1505
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.5
8.1
20
32
A03
ICPC
Fever
2.3
8.1
64
299
L04AD02
ATC
tacrolimus; systemic
22.4
8.0
11
5
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
8.0
175
1168
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
8.7
7.9
16
19
KCD02
NOMESCO Finland
Transurethral resection of bladder
15.3
7.7
12
8
D64.1
ICD-10 Finland
Secondary sideroblastic anaemia due to disease
45.7
7.7
9
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
25.4
7.6
10
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
25.4
7.6
10
*
B01AB10
ATC
tinzaparin; parenteral
2.5
7.6
47
196
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
7.5
26
78
D69.5
ICD-10 Finland
Secondary thrombocytopenia
81.2
7.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
81.2
7.4
8
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
7.3
7
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
+∞
7.3
7
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
7.3
7
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
7.3
7
*
L03.9
ICD-10 Finland
Cellulitis, unspecified
4.6
7.2
17
38
J01CA04
ATC
amoxicillin; systemic
1.7
7.2
359
2958
D64.0
ICD-10 Finland
Hereditary sideroblastic anaemia
30.5
7.2
9
*
H02AB09
ATC
hydrocortisone; systemic
6.2
7.1
18
30
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.4
7.1
25
76
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.6
7.0
42
172
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.4
6.9
25
77
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
6.9
51
231
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
6.8
61
300
D75.2
ICD-10 Finland
Essential thrombocytosis
40.6
6.8
8
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
40.6
6.8
8
*
D53.1
ICD-10 Finland
Other megaloblastic anaemias, not elsewhere classified
17.0
6.8
10
6
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
6.6
150
1001
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
12.5
6.6
11
9
SPAT1255
SPAT
Intravenous administration of medicine
2.5
6.6
43
184
XW000, ,
SPAT
70.7
6.4
7
*
WW200, ,
SPAT
0.5
6.3
59
1075
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.4
6.3
22
66
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
6.3
58
288
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
18.3
6.3
9
5
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
18.3
6.3
9
5
J05AB01
ATC
aciclovir; systemic
1.8
6.3
99
594
J05AX18
ATC
letermovir; oral
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
6.3
6
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
WW409
NOMESCO Finland
Other aferesis
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
9986/3-C42.1
ICD-O-3
Myelodysplastic syndrome with isolated del (5q) of bone marrow
+∞
6.3
6
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
6.3
6
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
J02AC05
ATC
isavuconazole; systemic
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
7.2
6.3
14
20
TQW99
NOMESCO Finland
Other minor procedure on skin
3.2
6.2
24
77
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.2
6.2
24
77
3039, ,
Kela drug reimbursment
27.0
6.2
8
*
ZXC96
NOMESCO Finland
Robot assisted procedure
27.0
6.2
8
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.9
6.1
18
48
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
354
423
25.64
316.24
14.0
2.1
260.37
238.87
u/l
2.97
338
397
221
64
60.62
307.65
1.4
1.1
146.93
19.94
u/l
8.97
198
57
223
39
101.61
307.65
3.5
1.2
—
—
—
0
0
199
109
29.48
264.19
3.2
1.6
—
—
—
0
0
332
463
19.01
260.82
7.2
2.1
68.98
65.18
e9/l
0.30
266
355
232
226
18.14
226.99
2.3
1.7
1.06
1.58
g/l
10.03
202
200
120
35
44.66
195.33
12.3
2.3
1.54
1.20
%
0.17
105
30
222
371
9.89
140.82
2.6
1.6
66.42
66.54
g/l
0.08
209
333
87
35
29.82
126.70
4.3
1.7
374.44
312.00
u/ml
—
9
6
154
227
9.32
106.05
3.2
1.9
11.19
11.35
g/l
0.13
144
208
128
153
10.87
103.81
2.3
1.3
59.45
52.71
mg/l
0.27
114
127
122
138
11.34
102.97
2.2
1.3
4.77
1.45
ratio
0.71
74
89
127
154
10.68
101.81
2.3
1.3
53.59
37.85
mg/l
0.33
111
129
102
92
13.64
100.13
3.5
1.2
—
—
—
0
0
101
93
13.33
97.78
3.1
1.2
—
—
—
0
0
61
20
34.55
94.36
1.4
1.7
—
—
—
0
0
61
20
34.55
94.36
1.4
1.7
—
—
—
0
0
240
639
6.25
91.85
2.9
2.5
40.63
22.38
%
22.73
233
588
261
752
6.11
91.38
2.9
2.5
19.52
12.11
umol/l
21.29
252
686
79
57
16.24
88.03
3.5
1.3
—
—
—
0
0
245
692
5.93
87.01
2.9
2.5
1.94
2.21
g/l
13.00
240
633
69
39
20.33
86.83
1.6
1.2
160.06
157.92
au/ml
0.03
16
12
124
186
8.51
82.94
2.0
1.3
1.30
1.17
g/l
0.31
114
171
124
195
8.10
79.41
2.1
1.3
3.91
4.15
g/l
2.29
114
171
124
195
8.10
79.41
2.1
1.3
3.68
3.67
g/l
0.01
114
171
124
195
8.10
79.41
2.1
1.3
6.25
7.68
g/l
12.68
114
171
58
27
24.14
79.14
4.3
1.4
—
—
—
0
0
59
29
22.90
78.75
4.3
1.4
—
—
—
0
0
118
179
8.30
77.92
2.1
1.3
2.86
3.04
g/l
0.74
108
155
291
1033
5.29
76.79
6.1
2.6
338.14
368.92
umol/l
4.20
275
864
63
44
16.22
71.08
1.3
1.1
273.42
287.58
u/ml
0.07
31
19
307
1216
4.89
68.47
3.2
2.3
2.89
2.86
mg/l
0.08
274
1033
105
162
7.92
67.88
2.1
1.3
1.26
0.24
g/l
1.39
93
138
102
168
7.36
61.90
1.9
1.3
11.74
10.75
g/l
0.89
90
144
239
834
4.54
61.62
4.0
1.8
—
—
—
0
0
48
27
19.54
60.09
4.2
1.1
—
—
—
0
0
48
27
19.54
60.09
4.2
1.1
—
—
—
0
0
48
27
19.54
60.09
4.2
1.1
—
—
—
0
0
72
82
10.07
59.33
1.9
1.2
—
—
—
0
0
186
560
4.67
57.65
7.6
4.7
1.10
1.02
mmol/l
2.54
176
507
374
1908
4.70
55.18
26.3
4.8
0.10
0.21
e9/l
24.94
330
1634
237
882
4.18
54.70
19.8
2.1
—
—
—
0
0
86
134
7.53
54.65
2.2
1.3
0.01
0.01
g/l
0.06
81
121
379
1977
4.68
53.58
41.4
5.4
3.34
4.50
e9/l
2.04
346
1701
343
1678
4.25
52.80
5.9
2.9
520.62
140.07
ug/l
20.35
320
1535
366
1878
4.45
52.52
23.7
4.9
1.44
1.75
e9/l
10.38
329
1632
89
151
6.94
52.16
3.0
3.5
—
—
—
0
0
44
28
17.12
51.77
1.5
1.4
—
—
—
0
0
371
1943
4.43
51.19
19.5
3.7
14.60
12.92
umol/l
1.81
361
1817
62
73
9.54
49.61
1.7
1.2
—
—
—
0
0
123
300
5.10
48.76
2.7
1.5
—
—
—
0
0
334
1663
3.98
48.70
21.0
2.4
—
—
estimate
—
0
0
55
59
10.34
47.10
1.9
1.3
—
—
—
0
0
183
626
4.02
46.39
6.6
2.3
0.80
0.83
mmol/l
2.07
173
580
59
71
9.28
46.36
2.0
1.2
—
—
—
0
0
78
130
6.91
46.31
2.0
1.3
0.00
0.00
g/l
-0.00
71
114
93
188
5.84
45.40
2.2
1.5
4.12
2.05
ug/l
0.29
81
158
184
643
3.93
45.05
3.0
1.8
—
—
—
0
0
235
983
3.60
43.57
2.1
1.8
1270.61
1160.08
nmol/l
0.86
180
749
187
680
3.78
42.88
2.8
1.8
29.28
29.77
s
0.39
179
656
45
44
11.13
41.00
1.8
1.3
—
—
—
0
0
42
41
11.08
38.27
2.5
2.4
—
—
—
0
0
331
1826
3.36
37.19
10.0
3.8
33.38
34.78
g/l
3.34
309
1689
43
47
9.91
36.15
1.7
1.3
—
—
—
0
0
338
1917
3.31
35.64
11.5
5.5
1.19
1.21
mmol/l
3.52
312
1726
164
612
3.49
35.21
1.6
1.2
2.84
2.84
g/l
0.01
128
347
69
135
5.76
34.56
1.9
1.2
—
—
—
0
0
33
26
13.51
34.34
1.4
1.1
—
—
—
0
0
360
2161
3.32
33.60
13.8
5.9
1.20
1.21
mmol/l
3.34
311
1844
46
61
8.20
33.23
1.2
1.4
—
—
—
0
0
155
602
3.27
30.67
3.2
1.8
—
—
—
0
0
39
13
32.37
29.89
4.6
1.2
—
—
—
0
0
39
13
32.37
29.89
4.6
1.2
—
—
—
0
0
39
13
32.37
29.89
4.6
1.2
—
—
—
0
0
39
13
32.37
29.89
4.6
1.2
—
—
—
0
0
115
385
3.57
28.68
9.9
2.0
9.65
8.81
umol/l
0.18
108
330
35
9
41.59
28.41
5.0
1.2
—
—
—
0
0
35
9
41.59
28.41
5.0
1.1
—
—
—
0
0
35
9
41.59
28.41
5.0
1.1
—
—
—
0
0
265
1437
2.78
27.97
2.8
1.8
19.27
19.75
nmol/l
0.20
248
1207
116
397
3.50
27.91
8.0
5.5
11.50
11.67
mmol/l
0.07
111
369
49
85
6.28
27.65
1.3
1.9
14.65
12.68
mg/l
0.36
41
78
29
6
51.10
24.54
8.3
1.7
1.34
1.50
%
—
29
6
329
2076
2.68
24.37
3.5
2.3
93.33
93.07
pmol/l
0.03
247
1080
69
181
4.26
24.17
5.1
1.5
—
—
—
0
0
95
313
3.51
24.02
2.8
1.6
—
—
—
0
0
93
316
3.38
22.32
1.9
1.8
0.17
0.20
g/l
2.31
82
284
26
31
8.79
20.30
1.0
1.0
—
—
—
0
0
61
166
4.04
20.25
3.1
1.5
—
—
—
0
0
166
819
2.53
19.78
2.2
1.6
2.17
1.48
mg/l
1.37
148
648
30
19
16.70
19.03
4.1
1.5
—
—
—
0
0
42
90
5.00
18.80
3.5
1.2
—
—
—
0
0
25
10
26.20
18.39
1.7
1.4
—
—
—
0
0
22
5
45.84
18.38
1.4
1.0
—
—
—
0
0
21
5
43.66
17.41
2.2
1.2
—
—
—
0
0
30
24
13.21
17.35
1.2
1.0
—
—
—
0
0
41
93
4.71
17.15
1.9
1.4
—
—
—
0
0
65
214
3.34
16.21
2.0
1.4
3.13
2.82
ug/l
0.20
48
160
310
2127
2.18
15.88
14.4
20.5
1.31
1.40
inr
2.35
272
1814
341
2441
2.22
15.53
10.1
4.5
7.05
6.89
mmol/l
0.69
331
2323
21
9
24.27
15.22
2.6
1.3
—
—
—
0
0
21
9
24.27
15.22
2.6
1.3
—
—
—
0
0
41
103
4.24
15.08
2.0
1.5
—
—
—
0
0
38
90
4.48
15.07
1.2
1.2
—
—
—
0
0
23
34
7.04
14.98
5.7
1.1
—
—
—
0
0
23
34
7.04
14.98
5.7
1.1
—
—
—
0
0
23
34
7.04
14.98
5.6
1.1
—
—
—
0
0
41
104
4.20
14.89
1.6
1.4
1.03
1.10
g/l
0.61
41
99
381
2877
2.32
14.87
26.2
5.4
79.17
78.88
u/l
0.05
369
2642
209
1255
2.14
14.87
2.9
2.2
48.53
60.72
u/l
2.38
187
1150
79
310
2.84
14.52
5.9
3.8
5.09
5.19
kpa
0.32
71
297
22
13
17.62
14.42
1.2
1.0
—
—
—
0
0
71
264
2.97
14.38
5.6
3.8
1.95
2.14
mmol/l
0.12
53
197
64
227
3.08
14.07
1.4
1.5
—
—
—
0
0
39
100
4.14
13.96
1.2
1.2
—
72.28
—
0
5
23
17
14.11
13.85
2.6
1.4
—
—
—
0
0
23
17
14.11
13.85
2.7
1.4
—
—
—
0
0
250
1644
2.03
13.57
3.6
2.3
—
—
—
0
0
50
158
3.40
13.26
6.7
4.4
25.42
24.98
mmol/l
0.41
43
143
47
145
3.47
12.93
1.8
1.6
10.99
8.44
iu/ml
0.27
14
35
39
106
3.90
12.90
1.4
1.6
0.02
0.15
iu/ml
—
7
24
17
7
25.05
12.54
1.1
1.1
—
—
—
0
0
36
96
3.96
12.22
1.2
1.2
3.60
3.09
u/ml
—
5
14
15
5
30.84
11.70
1.3
1.2
—
—
—
0
0
11
0
+∞
11.50
1.1
0.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
45
146
3.29
11.44
2.8
2.3
0.32
0.38
iu/ml
0.49
21
82
29
70
4.33
11.22
1.2
1.1
—
94.06
—
0
5
245
1681
1.89
11.00
4.2
3.3
2648.10
1969.71
ng/l
1.15
229
1465
42
136
3.28
10.71
1.4
2.1
33.00
38.91
u/l
0.95
35
112
19
17
11.56
10.63
1.1
1.1
—
—
—
0
0
23
30
7.98
10.49
5.6
1.2
—
—
—
0
0
23
31
7.72
10.29
5.6
1.2
—
—
—
0
0
23
31
7.72
10.29
5.6
1.2
—
—
—
0
0
25
58
4.48
10.16
1.4
1.4
918.47
1742.10
e6/l
0.80
17
41
32
92
3.65
9.78
1.4
1.6
—
—
—
0
0
14
8
17.95
9.45
1.0
1.0
15.10
17.34
umol/l
—
14
8
22
32
7.14
9.41
1.9
1.3
—
—
—
0
0
9
0
+∞
9.40
1.1
0.0
—
—
—
0
0
22
49
4.65
9.39
1.2
1.4
—
—
—
0
0
19
22
8.93
9.36
1.9
1.2
—
—
—
0
0
356
2850
1.84
8.84
7.2
4.3
26.11
13.71
mm/h
16.22
331
2597
204
1392
1.78
8.77
5.0
3.2
286.88
128.62
e6/l
0.44
162
1061
21
48
4.52
8.69
1.4
1.5
94323.00
47478.60
e6/l
—
10
30
179
1178
1.80
8.68
5.1
3.1
0.47
0.48
e6/l
0.01
138
864
217
1521
1.75
8.41
6.2
3.8
152.20
113.88
e6/l
0.17
166
1090
8
0
+∞
8.35
2.3
0.0
—
—
—
0
0
16
18
9.14
8.09
2.1
1.2
—
—
—
0
0
13
11
12.09
7.61
1.2
1.3
—
—
—
0
0
113
672
1.88
7.45
4.8
3.2
1.49
1.91
e6/l
0.38
51
329
16
21
7.83
7.44
2.1
1.2
—
—
—
0
0
167
1118
1.74
7.42
4.2
2.5
37.50
37.48
u/l
0.00
155
1054
274
2105
1.66
7.17
3.9
3.1
68.57
51.37
u/l
1.69
249
1920
26
83
3.25
6.81
1.1
1.3
—
147.50
—
0
8
192
1375
1.64
6.44
3.5
2.1
2.31
2.35
mmol/l
2.50
167
1191
10
7
14.54
6.42
1.0
1.0
105.10
100.00
%
—
10
7
116
726
1.78
6.40
4.6
3.0
1.31
1.16
e6/l
0.10
55
384
20
56
3.68
6.37
3.0
3.9
—
—
—
0
0
6
0
+∞
6.26
1.5
0.0
14.67
—
u/ml
—
6
0
26
88
3.06
6.20
2.2
2.2
32.05
36.86
umol/l
0.37
19
78
96
1485
0.56
5.98
2.1
1.9
1.30
1.24
mmol/l
0.31
83
1217
154
1062
1.65
5.90
1.9
1.8
100813551.70
4619361.14
pmol/l
0.47
123
866
32
126
2.64
5.82
1.4
1.2
—
—
—
0
0
54
270
2.12
5.77
1.4
1.6
1.84
1.71
%
0.26
39
218
13
20
6.64
5.59
1.8
1.1
39.77
38.26
g/l
0.26
13
20
28
106
2.74
5.50
3.5
3.8
2.19
1.21
index
0.46
16
58
143
985
1.63
5.45
3.5
2.4
5.15
4.72
e6/l
0.26
133
890
15
30
5.12
5.29
1.2
1.1
1.57
1.67
u/ml
—
7
12
83
497
1.80
5.26
4.3
5.4
31.43
33.19
%
0.71
53
312
5
0
+∞
5.21
1.4
0.0
—
—
—
0
0
11
15
7.47
5.16
1.3
1.5
—
—
—
0
0
94
587
1.74
5.16
7.7
5.8
0.92
1.14
mmol/l
0.18
81
477
256
2033
1.53
5.16
5.7
4.2
0.00
0.00
estimate
-0.00
53
434
259
2066
1.52
5.09
5.7
4.2
0.00
0.00
estimate
-0.00
53
445
59
320
1.96
5.07
2.3
2.0
38.39
34.08
u/l
0.33
49
248
32
138
2.41
4.86
2.4
3.9
0.77
0.86
nmol/l
0.68
18
113
259
2082
1.50
4.80
5.8
4.2
0.00
0.02
estimate
0.93
46
423
7
5
14.17
4.58
1.0
1.0
10.29
5.14
nmol/l
—
7
5
15
36
4.26
4.55
1.3
1.3
—
—
—
0
0
14
33
4.33
4.35
1.2
1.2
4.56
4.35
u/ml
—
9
17
11
20
5.60
4.31
1.0
1.3
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
6
11.81
4.28
1.4
1.5
76.71
68.33
%
—
7
6
132
950
1.53
4.03
4.7
4.6
63.44
314.74
ng/l
3.96
118
836
228
1831
1.45
4.01
5.9
4.5
29.96
48.30
ng/l
3.34
194
1459
6
5
12.12
3.77
5.3
1.0
17.83
15.80
u/ml
—
6
5
9
16
5.71
3.67
1.2
1.3
—
—
—
0
0
7
9
7.87
3.57
1.1
1.2
—
—
—
0
0
7
9
7.87
3.57
1.1
1.2
—
—
—
0
0
51
300
1.78
3.44
10.3
7.4
1.78
1.34
%
1.67
51
295
69
442
1.65
3.43
5.6
3.4
—
—
—
0
0
77
510
1.60
3.35
5.1
3.2
1.19
2.05
mmol/l
0.96
67
443
215
1750
1.40
3.33
2.5
2.4
79.18
79.98
nmol/l
0.15
193
1515
26
122
2.19
3.32
1.5
1.6
0.08
0.35
mg/l
4.07
12
48
36
192
1.94
3.29
2.0
2.1
417.83
638.36
ug/l
0.36
31
180
398
3608
1.49
3.28
62.6
16.9
28.78
27.49
mg/l
0.33
381
3016
13
43
3.08
3.27
1.3
1.1
—
—
—
0
0
180
1429
1.40
3.20
2.6
2.2
519.43
288.73
u/l
0.24
167
1334
155
1209
1.41
3.03
5.8
4.1
0.00
0.00
estimate
-0.00
44
390
14
51
2.79
3.01
2.2
1.4
89.21
90.82
%
0.66
14
51
22
101
2.23
2.97
1.8
1.3
—
—
—
0
0
22
101
2.23
2.97
1.8
1.3
—
—
—
0
0
81
559
1.53
2.96
1.3
1.3
23.60
11.64
u/ml
0.42
27
194
52
324
1.67
2.89
5.7
3.0
1.20
1.22
mmol/l
3.24
47
267
6
9
6.73
2.87
1.0
1.4
—
—
—
0
0
71
479
1.56
2.87
3.1
2.6
10.61
6.57
ug/l
0.25
52
410
7
14
5.05
2.73
1.0
1.0
1839.57
1837.36
miu/ml
—
7
14
7
14
5.05
2.73
1.0
1.1
—
—
—
0
0
9
25
3.65
2.58
1.1
1.9
13.64
17.43
umol/l
—
9
20
15
62
2.46
2.56
1.3
1.4
—
—
—
0
0
83
595
1.47
2.53
1.4
1.3
28.44
37.05
iu/ml
0.58
20
179
45
281
1.66
2.50
10.1
7.2
23.61
24.17
mmol/l
0.36
45
272
74
520
1.50
2.49
12.9
7.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
16
4.42
2.48
1.0
1.3
—
—
—
0
0
9
27
3.37
2.40
1.0
1.1
—
—
—
0
0
9
27
3.37
2.40
1.2
1.1
—
—
—
0
0
17
77
2.25
2.40
2.1
1.6
13.00
16.98
u/ml
0.55
17
57
314
2798
1.32
2.40
4.2
3.9
15.07
15.15
pmol/l
0.17
278
2483
5
8
6.30
2.37
1.0
1.3
—
—
—
0
0
10
33
3.07
2.37
1.0
1.1
—
—
—
0
0
9
28
3.25
2.31
1.0
1.1
—
—
—
0
0
16
72
2.26
2.30
5.7
1.5
35.69
34.22
u/ml
0.03
16
72
10
34
2.98
2.29
1.0
1.1
—
—
—
0
0
68
479
1.48
2.27
3.0
3.6
261.23
268.84
ng/l
0.05
59
444
9
29
3.14
2.23
1.0
1.1
—
—
—
0
0
9
29
3.14
2.23
1.0
1.1
—
—
—
0
0
5
9
5.60
2.22
1.0
1.1
—
—
—
0
0
5
9
5.60
2.22
1.0
1.3
—
—
—
0
0
7
19
3.72
2.15
1.1
1.1
—
—
—
0
0
7
19
3.72
2.15
1.0
1.1
—
—
—
0
0
6
14
4.32
2.15
1.0
1.1
—
—
—
0
0
13
55
2.40
2.14
2.1
3.6
—
22.25
—
0
20
19
96
2.02
2.08
1.3
1.2
—
—
—
0
0
19
96
2.02
2.08
1.3
1.2
—
—
—
0
0
23
128
1.83
1.93
2.8
2.0
101.67
129.62
g/l
3.13
15
101
6
17
3.56
1.84
1.0
1.3
—
—
—
0
0
18
99
1.85
1.59
1.2
1.3
235.64
300.25
ug/g
0.70
11
61
20
118
1.72
1.43
1.3
1.3
—
—
—
0
0
16
90
1.80
1.34
2.8
1.8
—
—
—
0
0
9
42
2.16
1.34
1.6
1.7
—
227.50
—
0
8
89
721
1.28
1.31
1.2
1.2
4.07
1.46
u/ml
0.46
16
182
27
180
1.53
1.23
4.9
3.2
1.43
1.48
mmol/l
0.10
27
174
81
991
0.78
1.23
3.2
3.1
0.90
0.80
ug/l
0.50
55
696
265
2875
0.84
1.22
89.2
22.7
327.50
331.39
g/l
6.81
260
2856
45
335
1.38
1.18
1.3
1.3
—
—
—
0
0
5
21
2.39
1.09
3.4
4.6
—
—
—
0
0
399
3812
1.22
1.06
57.0
21.8
138.61
139.70
mmol/l
12.53
388
3725
46
351
1.34
1.05
3.3
3.9
64.58
102.41
ng/l
5.11
38
295
7
34
2.07
1.03
1.0
1.2
—
—
—
0
0
399
3819
1.21
1.00
60.6
21.9
4.03
4.03
mmol/l
0.13
390
3730
9
52
1.74
0.93
1.9
1.8
12.79
10.48
mmol/l
—
9
52
6
28
2.16
0.91
3.0
1.8
2.90
134.82
u/ml
—
6
28
343
3599
0.85
0.90
5.2
6.5
2.01
2.45
mmol/l
18.71
298
3260
6
30
2.01
0.87
1.0
1.1
—
—
—
0
0
356
3398
1.16
0.81
5.6
5.1
2.14
2.03
mu/l
0.88
320
3053
334
3494
0.87
0.76
6.9
7.6
39.37
40.83
mmol/mol
1.99
299
3215
9
53
1.71
0.75
1.7
1.4
—
—
—
0
0
5
24
2.09
0.74
2.0
2.3
—
—
—
0
0
36
285
1.28
0.69
5.0
3.6
47.09
47.17
%
0.01
36
279
400
3871
1.16
0.67
95.6
25.2
96.75
91.94
fl
28.58
391
3804
400
3873
1.16
0.66
95.9
25.3
171.68
234.11
e9/l
15.30
384
3770
400
3873
1.16
0.66
95.6
25.3
3.33
4.39
e12/l
113.20
384
3749
400
3873
1.16
0.66
96.5
25.7
31.19
39.62
%
111.15
388
3805
400
3874
1.16
0.65
96.8
25.5
101.53
133.17
g/l
140.06
389
3807
38
306
1.26
0.64
1.3
1.5
—
—
—
0
0
389
3761
1.15
0.64
35.7
10.5
24.15
24.00
u/l
0.06
373
3591
398
3855
1.15
0.64
67.3
23.0
87.99
86.67
umol/l
0.28
387
3788
6
101
0.59
0.62
1.5
1.6
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
7
112
0.62
0.58
1.6
1.7
—
—
—
0
0
45
376
1.22
0.57
2.8
2.4
0.30
0.34
e6/l
0.14
45
353
192
1798
1.11
0.52
5.6
4.6
1.98
2.22
ug/l
0.61
166
1599
6
40
1.51
0.51
1.0
1.1
—
15.43
—
0
7
336
3477
0.90
0.51
4.7
5.5
1.27
1.42
mmol/l
7.59
289
3132
341
3519
0.90
0.47
4.7
5.6
3.69
4.31
mmol/l
20.56
291
3201
17
130
1.32
0.44
1.7
1.6
29.76
16.96
u/ml
—
5
20
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
136
1457
0.91
0.41
4.3
4.2
23.54
24.71
%
0.37
64
739
350
3411
1.09
0.35
49.4
16.6
71.58
70.36
ml/min/173m2
0.52
327
3177
33
286
1.16
0.32
3.3
2.6
55.55
56.31
ml/min/173m2
0.05
25
123
113
1067
1.08
0.26
4.7
3.8
0.00
0.00
estimate
-0.00
42
336
6
81
0.74
0.24
1.3
2.0
147.00
209.50
pmol/l
—
6
76
163
1564
1.06
0.24
6.1
4.3
0.00
0.02
estimate
0.96
47
347
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
7.6
—
10.34
—
0
10
13
112
1.16
0.14
2.3
2.4
172.00
77.95
ug/min
—
6
66
152
1563
0.96
0.14
3.4
3.4
6.45
7.35
mmol/l
2.26
129
1315
95
987
0.95
0.13
7.0
4.5
1.02
1.02
kg/l
0.18
69
662
14
123
1.14
0.12
1.1
1.0
—
—
—
0
0
24
258
0.93
0.09
1.8
1.4
—
—
—
0
0
8
74
1.08
0.07
2.3
2.4
1.20
1.18
mmol/l
—
8
74
8
76
1.05
0.07
2.3
2.4
106.50
105.18
mmol/l
—
8
76
357
3585
0.99
0.03
6.3
5.7
6.10
6.16
mmol/l
0.33
306
3212
332
3326
0.99
0.00
4.8
4.7
1.16
1.24
mmol/l
1.64
285
2956
159
1591
1.00
0.00
4.3
4.1
10.27
7.97
mg/mmol
0.32
107
1018
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
60.48
—
0
6
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
8.17
—
0
6
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
0.40
—
0
5
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
11.11
—
0
9
0
9
0.00
-0.00
0.0
1.0
—
10.31
—
0
9
0
9
0.00
-0.00
0.0
1.2
—
53.09
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
0.20
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MYELODYSP_SYNDR – Myelodysplastic syndrome
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).